KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $471000.0.

  • Twist Bioscience's Other Non Operating Income rose 60645.16% to $471000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$196000.0, marking a year-over-year increase of 9284.93%. This contributed to the annual value of -$903000.0 for FY2025, which is 6629.34% up from last year.
  • Per Twist Bioscience's latest filing, its Other Non Operating Income stood at $471000.0 for Q4 2025, which was up 60645.16% from $420000.0 recorded in Q3 2025.
  • Twist Bioscience's 5-year Other Non Operating Income high stood at $471000.0 for Q4 2025, and its period low was -$2.3 million during Q3 2024.
  • Its 5-year average for Other Non Operating Income is -$300950.0, with a median of -$212000.0 in 2022.
  • Per our database at Business Quant, Twist Bioscience's Other Non Operating Income plummeted by 176842.11% in 2021 and then skyrocketed by 60645.16% in 2025.
  • Twist Bioscience's Other Non Operating Income (Quarter) stood at -$156000.0 in 2021, then decreased by 0.64% to -$157000.0 in 2022, then skyrocketed by 80.25% to -$31000.0 in 2023, then tumbled by 200.0% to -$93000.0 in 2024, then skyrocketed by 606.45% to $471000.0 in 2025.
  • Its Other Non Operating Income was $471000.0 in Q4 2025, compared to $420000.0 in Q3 2025 and -$836000.0 in Q2 2025.